Research has demonstrated that ΔAKAP5, which incorporates the CaN inhibitory structural domain of AKAP5, inhibits isoproterenol (ISO)-induced cardiac hypertrophy in genetically modified mice (De Windt et al., 2001). Here, AKAP5 is linked to cardiac hypertrophy.